Wird geladen...
Evaluation of transarterial chemoembolization refractoriness in patients with hepatocellular carcinoma
BACKGROUND & AIM: In clinical practice, transarterial chemoembolization (TACE) has been widely used for the treatment of hepatocellular carcinoma (HCC) beyond as well as within guideline recommendations. Here we aimed to verify whether two consecutive non-responses could be an optimal criterion...
Gespeichert in:
| Veröffentlicht in: | PLoS One |
|---|---|
| Hauptverfasser: | , , , , , , |
| Format: | Artigo |
| Sprache: | Inglês |
| Veröffentlicht: |
Public Library of Science
2020
|
| Schlagworte: | |
| Online Zugang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7055892/ https://ncbi.nlm.nih.gov/pubmed/32130270 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1371/journal.pone.0229696 |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|